Mansour Mohamad Jihad, Mokbel Elias, Fares Eddy, Maddah Janah, Nasr Fadi
Lebanese University, Faculty of Medical Sciences, Hadath, Lebanon.
Mount Lebanon Hospital, Hazmieh, Lebanon.
J Med Case Rep. 2017 Sep 25;11(1):272. doi: 10.1186/s13256-017-1428-7.
Langerhans cell histiocytosis is a rare systemic disease characterized by the abnormal overproduction of histiocytes that tend to infiltrate single or multiple organ systems leading to significant tissue damage. It mainly affects - by order of decreasing frequency - the bone, the skin, the lymph nodes, the liver, and lungs. Gastrointestinal tract involvement is extremely rare in adults.
We describe the case of a 32-year-old Middle Eastern man with Langerhans cell histiocytosis involving his lungs and the colorectoanal part of his gastrointestinal tract, with complete resolution of gastrointestinal tract lesions following a non-standardized chemotherapy regimen.
Gastrointestinal tract lesions are a rare manifestation of Langerhans cell histiocytosis, especially when associated with extraintestinal involvement, such as the lungs. Chemotherapy protocols have not been well established for the treatment of the disease. The clinical impact of the effective chemotherapy regimen used to treat this uncommon presentation of Langerhans cell histiocytosis will be viewed in this case report.
朗格汉斯细胞组织细胞增多症是一种罕见的全身性疾病,其特征是组织细胞异常过度增殖,这些组织细胞倾向于浸润单个或多个器官系统,导致严重的组织损伤。按受累频率递减顺序,它主要影响骨骼、皮肤、淋巴结、肝脏和肺。胃肠道受累在成人中极为罕见。
我们描述了一名32岁中东男性朗格汉斯细胞组织细胞增多症患者的病例,其肺部和胃肠道的结直肠肛门部分均受累,在接受非标准化化疗方案后,胃肠道病变完全消退。
胃肠道病变是朗格汉斯细胞组织细胞增多症的罕见表现,尤其是与肠道外受累(如肺部)相关时。治疗该疾病的化疗方案尚未完全确立。本病例报告将探讨用于治疗这种罕见的朗格汉斯细胞组织细胞增多症表现的有效化疗方案的临床影响。